Patents by Inventor ALS THERAPY DEVELOPMENT INSTITUTE

ALS THERAPY DEVELOPMENT INSTITUTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the Treatment of Neurodegenerative Diseases
    Publication number: 20130295092
    Abstract: Disclosed are methods for treating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's Disease Parkinson's Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Lateral Sclerosis, Spinal Muscular Atrophy, Kennedy's Disease, and Spinocerebellar Ataxia.
    Type: Application
    Filed: April 8, 2013
    Publication date: November 7, 2013
    Inventor: ALS Therapy Development Institute
  • TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
    Publication number: 20130150454
    Abstract: Methods and therapeutic compositions are disclosed for treating neurodegenerative disorders and, in particular Amyotrophic Lateral Sclerosis, using sphingosine1-phosphate receptor modulators, such as fingolimod or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
    Type: Application
    Filed: November 29, 2012
    Publication date: June 13, 2013
    Applicant: ALS THERAPY DEVELOPMENT INSTITUTE
    Inventor: ALS THERAPY DEVELOPMENT INSTITUTE